Estrella Immunopharma, Inc. logo

ESLAEstrella Immunopharma, Inc.

ESLA Stock Price, Valuation & Chart | Estrella Immunopharma, Inc.

Compare

ESLA Historical price chart

ESLA Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization29.44M
PE Ratio-2.8
EPS-0.25
Trading Volume17.35K
Today's High/Low0.72/0.69
Dividend Yield0.00
52 Week High/Low3.15/0.62
Shares Outstanding42.67M
ESLA Financial Statement
ESLA Analyst ratings
ESLA Analysis & performance metrics

ESLA Company profile

Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's…

ESLA Management team

Management
Jiandong XuCFO
Chief Financial Officer
Cheng Liu Ph.D.CEO
Chief Executive Officer, President & Director
Total 2 executives

ESLA Frequently asked questions

What is Estrella Immunopharma, Inc. (ESLA) Stock Price?

Current stock price of Estrella Immunopharma, Inc. (ESLA) stock is $0.690. The stock price is -0.22% lower in the session. The intraday range can be seen from this page. Volume of Estrella Immunopharma, Inc. (ESLA) stock is 17.35K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Estrella Immunopharma, Inc. (ESLA) stock price going up or down today?

The stock price of Estrella Immunopharma, Inc. (ESLA) can change with earnings, company news, and overall market sentiment. Estrella Immunopharma, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Estrella Immunopharma, Inc. stock expensive at its current price?

Whether Estrella Immunopharma, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ESLA on this page is -2.80. EPS on this page is -0.25. Compare those figures with peers and growth expectations before deciding if the current Estrella Immunopharma, Inc. price is justified.

How has the stock price of Estrella Immunopharma, Inc. (ESLA) performed historically?

Historical performance for Estrella Immunopharma, Inc. (ESLA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ESLA reacted to past earnings and market events.

Should I buy Estrella Immunopharma, Inc. (ESLA) stock, at this price?

Buying Estrella Immunopharma, Inc. (ESLA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.